EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›HNVR

HNVR

Hanover Bancorp, Inc. /MD

Next earnings Jul 21, 2026 · consensus $0.58 EPS, $20.2M rev

Last earnings +5.4% on 2026-04-27

Sell
$23.25
▼ -0.21%
$23.25▲ +9.09%
over 1Y
L $19.90EODHDH $24.13
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.2%
1W-0.2%
1M-0.4%
3M+10.1%
YTD+3.0%
1Y+9.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Overvalued
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Sell

Mixed signals in the latest filings.

Return on equity 3.7% · latest

The read

Weak on both the fundamentals and the price — little to like at the current level.

Hanover Bancorp, Inc. /MD shows limited reported revenue, and 3.7% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income—————
Net income$10.9M$23.6M$15.2M$12.3M$7.49M
Diluted EPS$2.28$3.68$2.05$1.66$1.00
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF13.7
PEG (trailing)—
Earnings yield4.5%
FCF yield7.3%

Quality & risk

ROIC (est.)—
Free cash flow$12.2M
Total debt$101M
Net cash$108M

Capital returns

Buyback yield1.1%
Dividend yield (est.)1.8%
Shareholder yield2.9%
Shares Δ YoY-0.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Reg FD disclosure2026-06-04
  2. 8-K Officer / director change2026-06-01
  3. 10-Q Quarterly report2026-05-08
  4. 8-K Earnings results2026-04-27
  5. DEF 14A Proxy statement2026-04-23
  6. 10-K Annual report2026-03-13
  7. 8-K Material agreement2026-03-12
  8. 8-K Officer / director change2026-02-19
  9. 8-K Earnings results2026-01-29

Recent filings

all on EDGAR ↗
EFFECTFiling2026-06-18open ↗424B3Filing2026-06-18open ↗4Period ending 2026-06-122026-06-16open ↗4Period ending 2026-06-102026-06-12open ↗S-4Filing2026-06-04open ↗4Period ending 2026-06-022026-06-04open ↗8-KPeriod ending 2026-06-042026-06-04open ↗4Period ending 2026-05-292026-06-02open ↗8-KPeriod ending 2026-05-282026-06-01open ↗4Period ending 2026-05-272026-05-29open ↗4Period ending 2026-05-192026-05-21open ↗SCHEDULE 13G/AFiling2026-05-18open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueB-
GrowthF
ProfitabilityD
Financial healthA-
Momentum—
  • ✓Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$7.65

Overvalued -67% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.00 × (8.5 + 1.5 × 0.0% growth) × 0.90 quality = 7.7× multiple. An estimate, not a price target.

Revenue
—
Net margin
—
ROE
3.7%
P/E
23.3

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$7.49M-39.3%
Diluted EPS$1.00-39.8%
Cash & equivalents$209M+28.3%
Total assets$2.38B+3.1%
Total liabilities$2.18B+3.2%
Stockholders' equity$200M+1.8%
L/E: 10.90x

Frequently asked

Is Hanover Bancorp, Inc. /MD (HNVR) a buy?
HNVR currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is HNVR's fair value?
A Modified-Graham model based on HNVR's SEC fundamentals estimates a fair value of about $7.65. It is an estimate from reported earnings, not a price target.
Is HNVR overvalued or undervalued?
Against a Modified-Graham fair-value estimate, HNVR currently appears overvalued relative to its SEC-grounded earnings power.
What is Hanover Bancorp, Inc. /MD's quality score?
HNVR scores 52.29411764705882/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001828588, latest 10-Q filed 2026-05-08) · EODHD · as of 6/26/2026, 8:22:11 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 8 sales

2026-06-15
Golden Robert
Director
Sell661.00 @ $24.21$16.0K
2026-06-12
Golden Robert
Director
Sell3.76K @ $24.02$90.4K
2026-06-10
Golden Robert
Director
Sell8.42K @ $24.20$204K
2026-06-02
Golden Robert
Director
Sell1.85K @ $23.10$42.7K
2026-05-29
Golden Robert
Director
Sell1.51K @ $23.71$35.9K
2026-05-27
Golden Robert
Director
Sell1.29K @ $23.53$30.5K
2026-05-20
Golden Robert
Director
Sell1.01K @ $23.01$23.3K
2026-05-19
Golden Robert
Director
Sell2.26K @ $22.79$51.5K
2026-05-06
Golden Robert
Director
Exercise10.0K @ $13.00$130K
2026-05-01
Diiorio Lisa A
FSVP & Chief Accounting Off.
Exercise6.00K @ $13.00$78.0K
2026-05-01
Diiorio Lisa A
FSVP & Chief Accounting Off.
Tax3.88K @ $23.72$92.0K

Dividends

Quarterly
Yield (TTM)
1.7%
Annual / share
$0.40
Last ex-date
2026-05-11
Last amount
$0.10
ex 2026-05-11paid 2026-05-18$0.10
ex 2026-02-12paid 2026-02-26$0.10
ex 2025-11-13paid 2025-11-20$0.10
ex 2025-08-06paid 2025-08-13$0.10
ex 2025-05-07paid 2025-05-14$0.10
ex 2025-02-12paid 2025-02-19$0.10

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-27Miss -1.0% est▲ +0.09%8-K ↗
2026-01-29Miss -100.0% est▲ +0.93%8-K ↗
2025-10-30Miss -4.7% est▲ +2.48%8-K ↗
2025-07-23Miss -40.9% est▲ +0.85%8-K ↗
2025-04-23—▲ +3.05%8-K ↗
2025-01-29—▲ +0.95%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Hanover Bancorp, Inc. Reports First Quarter 2026 Results Highlighted by Continued Margin Expansion and Declares $0.10 Quarterly Cash DividendBullish
globenewswire.com· 2026-04-27
Hanover Bancorp, Inc. Completes $35 Million Private Placement of Subordinated NotesBullish
globenewswire.com· 2026-03-12
Hanover Bancorp, Inc. Announces the Addition of a New Chief Commercial Real Estate Lending OfficerBullish
globenewswire.com· 2026-01-29
Hanover Bancorp, Inc. /NY Announces Drop In Q3 ProfitBullish
nasdaq.com· 2025-10-30
Hanover Bancorp GAAP EPS of $0.47 in-lineBullish
seekingalpha.com· 2025-10-30
Hanover Bancorp declares $0.10 dividendBullish
seekingalpha.com· 2025-10-30

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score52 vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity3.7% vs 12.3%
P/E23.3 vs 25.5